Načítá se...
Proton pump inhibitor use and cancer mortality
Proton pump inhibitors (PPIs) are commonly used as a supplement to cancer therapy. Yet, their effect on cancer mortality is largely unknown. Using data from Danish nationwide registries and Cox proportional hazards models, we estimated hazard ratios with 95% confidence intervals (CIs) for cancer-spe...
Uloženo v:
| Vydáno v: | Int J Cancer |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7611279/ https://ncbi.nlm.nih.gov/pubmed/29658114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31529 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|